The Centre for Research and Information on Substance Abuse (CRISA), in collaboration with Community Intervention Network on Drugs in Nigeria (CIND) and other partners, will organise the 3rd Biennial National Symposium on Drug Policy in Nigeria. The symposium will be held in October in Abuja at a venue to be determined. 
The major theme of the symposium is “Community responses to drug problems in Nigeria”. 

We invite researchers, policy makers, treatment experts and students to submit abstracts of their papers on all issues relating to responses to alcohol and drug problems at the community level for presentation at the symposium. Poster presentations and proposals for panel discussions and special events are also welcome. The programme will include capacity building workshops directly targeting CSOs and young professionals working in prevention and treatment and doing research on drugs in Nigeria. 

We are particularly interested in papers that address the following sub-themes in Nigeria: 

- Changing patterns of drug use in the local communities 

- Marketing and promotion of alcohol and other drugs in the community 

- Cultural beliefs and practices relating to drug use 

- Production and use of indigenous and new psychoactive drugs 

- The roles of local communities in the prevention of drug use (including traditional and religious institutions, and women and youth groups) Community-based treatment for drug use disorders 

Those who are interested in presenting the findings of their empirical research, review of alcohol and drug policy, evaluations of interventions and best practices from community initiatives in drug prevention and treatment should submit an abstract of not more than 250 words by e-mail to the Local Organizing Committee ( on or before the abstract deadline shown below. 

Important dates 

11 August - Deadline for abstract submission 
22 September - Deadline for full paper submission 
24 October - Arrival 
25 October - Conference opens 
26 October - Conference closes 
27 October - Departure 

Guidelines for abstract preparation 

Title of the paper (capitalized) 
Name(s) and affiliation(s) of authors 
First and last name of author(s) should be written in full 
Provide contact information for the lead author 
The abstract should be one paragraph with no sub-headings 
Do not exceed 250 words 
Submit as a word document 

Information on registration, travel and accommodation will be available at CRISA website in due course. 

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert

Thumbnail Flickr CC